Home page noteworthy

Noteworthy


February 2 – DTBE announced that beginning Monday, February 6, 2023, a new targeted next generation sequencing (tNGS) assay will be implemented as the primary method for CDC’s Molecular Detection of Drug Resistance (MDDR) service. Link to 02.02.23_DCL


January 31 – TAG Launches 2022 TB Treatment Pipeline Report. TAG released its annual TB Treatment Pipeline Report, which puts results from phase III trials in context, and sheds light on the next generation of TB treatment shortening research.


December 5 – As of 12/2/2022, NTCA’s “tbcontrollers.org” email accounts are down. While our provider Rackspace works to restore service, if you have a general question, please email ntca.inbox@gmail.com. Updates will be posted here and sent to members via Constant Contact.

Bookmark the permalink.